◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
NVAX
NVAX
(NVAX)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
Simply Wall St.
·
vor 14 Std.
How Expanded Nuvaxovid Royalties and Partner-led Execution Could Shape Novavax’s (NVAX) Investment Narrative
Simply Wall St.
·
vor 16 Std.
Novavax (NVDA) Following Updated Nuvaxovid Approval Faces A Wide Fair Value Debate
Simply Wall St.
·
vor 20 Std.
Has Novavax (NVAX) Fallen Far Enough To Look Cheap?
Stocktwits
·
vor 1 Tagen
NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow Open
GuruFocus.com
·
vor 1 Tagen
Pfizer's Updated COVID Shot Ships Into a Smaller Market
MT Newswires
·
vor 1 Tagen
Novavax's Nuvaxovid Approved in US, EU, Japan for 2026-2027 Season
Frag BlackSpecter AI über NVAX
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist NVAX kaufenswert?
NVAX Earnings Analyse
NVAX Bewertung
AI Chat öffnen →